Immune response to SARS-CoV-2: B-lymphocyte releases antibodies that bind to and mark coronaviruses. … [+]
Recent studies indicate the previously unknown protective value of non-neutralizing monoclonal antibodies against SARS-CoV-2. Throughout the pandemic, the search for monoclonal antibody treatments centered around neutralizing capacity. How well can an antibody neutralize the latest variants? As new variants arose, previously neutralizing antibodies…
Continue Reading
News Source: www.forbes.com